Effects of Tapcom Combination Ophthalmic Solution Switched from Tapros 0.0015% and Timoptol XE 0.5% Solutions
Not Applicable
- Conditions
- primary open angle glaucoma, normal tension glucoma or ocular hypertension
- Registration Number
- JPRN-UMIN000016885
- Lead Sponsor
- Kitasato University
- Brief Summary
Refer to published paper
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
some corneal abnormality or other diseases which may interfere with accurate IOP measurement history of corneal refractive surgery bronchial asthma or a history of the said disease bronchospasm or severe chronic obstructive pulmonary disease cardiac insufficiency, sinus bradycardia, atrioventricular block (II, or III degree) or cardiogenic shock
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IOP reduction
- Secondary Outcome Measures
Name Time Method